Restart Life Sciences Corp.
HEAL
Rank in Stocks
#35835
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
Share Price
$0.05137558
Last synced: 2026-10-16
Market Cap
$3.21M
Change (1 day)
0.00%
Change (1 year)
78.84%
Country
CA
Trade Restart Life Sciences Corp. (HEAL)
Category
Healthcare
Market Capitalization of Restart Life Sciences Corp.(HEAL)
Market Cap: $3.21M
As of October 2026 Restart Life Sciences Corp. has a market cap of $3.21M. This makes Restart Life Sciences Corp. the world's 35835th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Restart Life Sciences Corp. from 2006 to 2026
HEAL compared with Top 5 Most Popular stocks
